Clinical Trial Update: Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update concerns CM313 for relapsed/refractory aplastic anemia, a subcutaneous injection studied in Phase 1/2; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CM313

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Aplastic Anemia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING